He Cao

Hangzhou, 310000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Research Advances in Obstructive Sleep Apnea and Lung Cancer Comorbidity

Research Advances in Obstructive Sleep Apnea and Lung Cancer Comorbidity

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 13, 2026

KIAA0101 in human cancers: From biomarker discovery to therapeutic targeting.

KIAA0101 in human cancers: From biomarker discovery to therapeutic targeting.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: October 29, 2025

Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer

Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 15, 2023

A novel stilbene derivative (GMQ3) suppressed proliferation and induced apoptosis in lung cancer via the p38-MAPK/SIRT1 pathway.

A novel stilbene derivative (GMQ3) suppressed proliferation and induced apoptosis in lung cancer via the p38-MAPK/SIRT1 pathway.

Journal: Biochemical pharmacology

Published: August 03, 2021

Ipsilateral breast metastasis from lung adenocarcinoma harboring anaplastic lymphoma kinase or ROS1 rearrangement and significant response after targeted therapy: report of two cases.

Ipsilateral breast metastasis from lung adenocarcinoma harboring anaplastic lymphoma kinase or ROS1 rearrangement and significant response after targeted therapy: report of two cases.

Journal: Chinese medical journal

Published: June 20, 2020

First-in-Human Phase 1 Study of ES-072, an Oral Mutant-Selective EGFR T790M Inhibitor, in Non-Small-Cell Lung Cancer.

First-in-Human Phase 1 Study of ES-072, an Oral Mutant-Selective EGFR T790M Inhibitor, in Non-Small-Cell Lung Cancer.

Journal: Clinical lung cancer

Published: May 14, 2020

Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics.

Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics.

Journal: Journal of Cancer

Published: May 07, 2020

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study.

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 23, 2020

Overexpression of KIAA0101 Promotes the Progression of Non-small Cell Lung Cancer.

Overexpression of KIAA0101 Promotes the Progression of Non-small Cell Lung Cancer.

Journal: Journal of Cancer

Published: March 13, 2020

Quantitative volumetric assessment of the solid portion percentage on CT images to predict ROS1/ALK rearrangements in lung adenocarcinomas.

Quantitative volumetric assessment of the solid portion percentage on CT images to predict ROS1/ALK rearrangements in lung adenocarcinomas.

Journal: Oncology letters

Published: December 11, 2019

Investigation on the prognostic impact of concurrent genomic alterations in crizotinib-treated EML4-ALK-rearranged advanced non-small cell lung cancer patients.

Investigation on the prognostic impact of concurrent genomic alterations in crizotinib-treated EML4-ALK-rearranged advanced non-small cell lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 27, 2019

Molecular features of lung adenocarcinoma in young patients.

Molecular features of lung adenocarcinoma in young patients.

Journal: BMC cancer

Published: February 12, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026